Physician profile
Michael Ha
NPI 1508410820
$1,076.55
in general payments reported to CMS, 2019-2025
9 companies · $14.44 in 2025
The $14.44 reported for 2025 was less than what a typical Periodontics provider received nationally (typical 2025 total: $111).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.58 · 2020: $85.10 · 2021: $644 · 2022: $294 · 2023: $15.42 · 2025: $14.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $29.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $29.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohorizons Implant Systems INC. | $374.43 | 2020-2022 | |
| Geistlich Pharma, North America, INC. | $297.10 | 2021 | |
| Straumann USA LLC | $186.81 | 2021-2025 | |
| Salvin Dental Specialties, INC. | $109.99 | 2021 | |
| Zimvie INC. | $27.04 | 2022 | |
| Dentsply Sirona INC | $24.43 | 2020 | |
| Keystone Dental INC. | $23.58 | 2019 | |
| Nobel Biocare USA | $21.36 | 2021 | |
| Hu-Friedy Mfg. Co., LLC | $11.81 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Ha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.